A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.

The purpose is to explore the efficacy and safety of the SYSUCC-RMS regimen for pediatric RMS patients and to explore the impact of concurrent radiotherapy and chemotherapy on the survival rate of low-risk, medium risk, high-risk, and extremely high-risk patients in children.

Trial Details

NCT ID
NCT06836492
Phase
PHASE3
Sponsor
Yizhuo Zhang
Status
RECRUITING
Cancer Type
Rhabdomyosarcoma Sarcoma
Interventions
  • VAC,VAC/VII,CAV/IE
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25

Key Eligibility Criteria

  • 0 years \< age \< 18 years old, regardless of gender;
  • Tumor patients diagnosed by histopathology or bone marrow cytology;
  • Patients are treated for the first time;
  • ECoG score ≤ 2;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Rhabdomyosarcoma Sarcoma Trials on Trialify →